2Chesebro JH, Badimon JJ, Ortiz AF, et al. Comjunctive antithrombotic therapy for throm bolys in my ocnrdia infarction[J] .An J Cardiol, 1993,72(19):66G.
4Noto D, Barbagallo CM, Cerfalu' AB, et al. Factor Ⅷ activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11-year follow-up. Thromb Haemost, 2002; 87:206- 210
5Pooh MC, d'Oiron R. Recombinant activated factor Ⅷ (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor Ⅷ a and Congenital Platelet Disorders Group. Blood Coagul Fibrinolysis, 2000 ; 11 (Suppl 1) :S5
6Mercier E, Branger B, Vecina F, et al. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency. HematolJ, 2001; 2:18-25
7Oda H, Ohno M, Ohashi H. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease. Adv Perit Dial, 2000; 16:152- 155
8Salomaa V, Rasi V, Kulathinal S, et al. Hemostatic factors as predictors of coronary events and total mortality: The FINRISK'92 Hemostasis Study. Arterioscler Thromb Vasc Biol, 2002; 22:353-358
9Guth HJ, Klingbeil A, Wiedenhoft I, et al. Presence of factor-Ⅷ and-ⅩⅢ activity in ultrafiltrate during hemofiltration. Int J Artif Organs, 1999; 22:482 - 487
